Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)

The provision of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme. The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to 11.5 million doses. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. The awarding of lots is not appropriate for this procurement.